Salarius Pharmaceuticals, Inc. (SLRX) News & Corporate Actions | Announcements, Board Meetings, Splits, Bonuses, Rights Issues

{
  "main_header": {
    "sid": 1160224,
    "name": "Salarius Pharmaceuticals, Inc.",
    "stock_name": "Salarius Pharmaceuticals, Inc.",
    "full_name": "Salarius Pharmaceuticals, Inc.",
    "name_url": "stocks-analysis/salarius-pharmaceuticals-inc",
    "exchange": 210,
    "exchangecode": "NAS",
    "country_id": 2,
    "currency": "USD",
    "cmp": "0.87",
    "chg": 0.02,
    "chgp": "1.77%",
    "dir": 1,
    "prev_price": "0.86",
    "mcapval": "2.37",
    "mcap": "",
    "scripcode": "",
    "symbol": "",
    "ind_name": "Miscellaneous",
    "ind_code": 3205,
    "indexname": "S&P 500",
    "isin": "US79400X3052",
    "curr_date": "Dec 04",
    "curr_time": "",
    "bse_nse_vol": "53.03 k",
    "exc_status": "Active",
    "traded_date": "Dec 04, 2025",
    "traded_date_str": "2025 12 04",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-registerF-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/salarius-pharmaceuticals-inc-1160224-210&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Is Salarius Pharmaceuticals, Inc. technically bullish or bearish?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/is-salarius-pharmaceuticals-inc-technically-bullish-or-bearish-3548019",
        "imagepath": "",
        "date": "2025-09-20 20:08:01",
        "description": "As of 25 August 2025, the technical trend for Salarius Pharmaceuticals, Inc. has changed from mildly bearish to mildly bullish. However, the overall stance remains mixed. The weekly MACD and RSI are bearish, while the monthly MACD is mildly bullish, indicating some potential for upward movement. The moving averages are bearish on a daily basis, and the Dow Theory shows no trend weekly but is bearish monthly. Despite this, the On-Balance Volume (OBV) is bullish on both weekly and monthly time frames, suggesting accumulation.\n\nIn terms of performance, the stock has significantly underperformed the S&P 500 across all observed periods, with a year-to-date return of -83.48% compared to the S&P 500's 12.22%. This stark contrast highlights the challenges facing the stock despite the recent trend change...."
      },
      {
        "title": "Salarius Pharmaceuticals Stock Plummets to 52-Week Low of $4.23",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/salarius-pharmaceuticals-stock-plummets-to-52-week-low-of-423-3537161",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/9/SalariusPharmac_priceRelatedfactors_3537161.png",
        "date": "2025-09-19 13:13:57",
        "description": "Salarius Pharmaceuticals, Inc. has reached a new 52-week low, contrasting with its previous high. Despite a year-over-year performance increase, the company faces volatility and challenges in the industry. With a market cap of USD 2 million, it operates at a loss and has notable financial metrics that raise concerns."
      }
    ],
    "total": 7,
    "sid": "1160224",
    "stock_news_url": "https://www.marketsmojo.com/news/salarius-pharmaceuticals-inc-1160224"
  },
  "announcements": "",
  "corporate_actions": {
    "msg": "No corporate action Found"
  }
}

News and Views

Is Salarius Pharmaceuticals, Inc. technically bullish or bearish?

2025-09-20 20:08:01

As of 25 August 2025, the technical trend for Salarius Pharmaceuticals, Inc. has changed from mildly bearish to mildly bullish. However, the overall stance remains mixed. The weekly MACD and RSI are bearish, while the monthly MACD is mildly bullish, indicating some potential for upward movement. The moving averages are bearish on a daily basis, and the Dow Theory shows no trend weekly but is bearish monthly. Despite this, the On-Balance Volume (OBV) is bullish on both weekly and monthly time frames, suggesting accumulation. In terms of performance, the stock has significantly underperformed the S&P 500 across all observed periods, with a year-to-date return of -83.48% compared to the S&P 500's 12.22%. This stark contrast highlights the challenges facing the stock despite the recent trend change....

Salarius Pharmaceuticals Stock Plummets to 52-Week Low of $4.23

2025-09-19 13:13:57

Salarius Pharmaceuticals, Inc. has reached a new 52-week low, contrasting with its previous high. Despite a year-over-year performance increase, the company faces volatility and challenges in the industry. With a market cap of USD 2 million, it operates at a loss and has notable financial metrics that raise concerns.

View All News